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ABSTRACT: In cell therapies, it is advantageous to encapsulate live
cells in protective, semipermeable microparticles for controlled release
of cytokines, growth factors, monoclonal antibodies, or insulin. Here, a
modiﬁed electrospraying approach with an organic solution of
poly(lactide-co-glycolide) (PLGA) polymer is used to create synthetic
PLGA capsules that eﬀectively protect live cells. Using a design of
experiment (DOE) methodology, the eﬀect of governing jetting
parameters on encapsulation eﬃciency, yield, and size is systematically
evaluated. On the basis of this analysis, the interaction between bovine
serum albumin concentration and core ﬂow rate is the most dominant
factor determining core encapsulation eﬃciency as well as the
microcapsule size. However, the interaction between shell solvent
ratio and shell ﬂow rate predominantly deﬁnes the particle yield. To
validate these ﬁndings, live cells have been successfully encapsulated in
microcapsules using optimized parameters from the DOE analysis and have survived the electrohydrodynamic jetting process.
Extending the currently available toolkit for cell microencapsulation, these biodegradable, semi-impermeable cell-laden
microcapsules may ﬁnd a range of applications in areas such as tissue engineering, regenerative medicine, and drug delivery.
1. INTRODUCTION
In recent years, cell-based therapies have emerged as promising
strategies intended to augment conventional drug-based
therapies. In particular, cell therapies have been developed for
local production of a range of biologics such as cytokines,
growth factors, monoclonal antibodies, and insulin.1,2 However,
the direct administration of foreign cells using intradermal
techniques has been plagued by immunorejection of the
transplanted cells. Alternatively, encapsulation of live cells in
microparticles has been evaluated as a potential method to
mitigate unwanted host responses.3 Microcapsules can provide
a protective environment for cells to proliferate and generate
therapeutic agents, while permitting bidirectional diﬀusion of
oxygen, nutrients, and metabolites.4,5 So far, natural hydrogels
have been the material of choice for microencapsulation of cells
because their processing is done under physiologically
compatible conditions.6 In particular, agarose, alginate, and
collagen are widely used natural hydrogels for cellular
encapsulation.7 Although the permeable nature of these
hydrogels permits cell proliferation and rapid diﬀusion, the
particle design space is potentially restricted by factors such as
temperature, pH, or incorporation of cross-linking agents
needed to crosslink the natural hydrogels.8,9 In principle,
synthetic polymers provide a wider experimental spectrum that
allows for systematic changes in the particle size, porosity, and
membrane thickness. However, a major challenge has been to
avoid exposure of cells to organic solvents and nonphysiological
temperatures needed for the processing of synthetic polymers.
A potential solution oﬀers the use of a core−shell structure,
wherein the cells are encapsulated in the core and are fully
separated from the polymer shell throughout the fabrication
process.
The structure of core−shell particles creates a biologically
safe environment for the cell in the core, while utilizing
polyesters such as poly(lactide-co-glycolide) (PLGA) in the
shell creates a protective layer that allows for the study of
individual cells and provides the means to deliver the cells into
various environments such as low/high pH conditions and high
enzyme tissues. It also allows individual cell entrapment, which
has important applications in single cell-based biology,
development of biosensor circuits, and bioreactors. It also
protects the cells against lethal stressors resembling the
sporulation process in nature.10,11 Moreover, because the
viability of the cells inside the particles depends on the
permeability of the particles, individual cell encapsulation
eliminates the problem of cells farther from the barrier
receiving less nutrients.7
Encapsulation of cells in microparticles has been achieved
using several diﬀerent techniques, such as electrostatic spraying,
emulsion, micro-nozzle array, interfacial polymerization, and
extrusion methods.12−16 Using a modiﬁed electrospraying
approach, we now report a new type of polymer capsule that
is composed of PLGA shells protecting live cells inside the core.
Received: May 8, 2017
Accepted: June 7, 2017
Published: June 21, 2017
Article
http://pubs.acs.org/journal/acsodf
© 2017 American Chemical Society 2839 DOI: 10.1021/acsomega.7b00570
ACS Omega 2017, 2, 2839−2847
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
2. RESULTS AND DISCUSSION
To prepare polymer capsules containing live cells, the PLGA
solution and a cell-loaded core solution are simultaneously
driven through a needle using a suﬃciently high electrical
voltage. This work has been inspired by past studies that report
signiﬁcant control over critical properties of multicompartmen-
tal nano- and microparticles.17−20 As previously reported, the
viscoelastic polymeric solution at the tip of the needle forms
into a droplet and becomes stable under an applied electric
potential. This stability is the result of the equilibrium between
the applied electric force and the surface tension in the
viscoelastic droplet.21 Rapid evaporation of solvents from both
the shell and the core results in the fabrication of core−shell
microparticles. Typically, particles fabricated using this
technique feature small size distribution with high surface to
volume ratios that enhance the transfer of oxygen and
nutrients.22 The schematic of this process is depicted in Figure
1.
Control over encapsulation eﬃciency, yield, and size of the
particles are of signiﬁcant importance for cell-based therapies.
Importantly, this study utilizes a design of experiment (DOE)
methodology to identify optimum parameters for micro-
encapsulation of living cells in biodegradable polymer capsules.
DOE methodology not only predicts the main factors aﬀecting
the encapsulation eﬃciency, yield, and size of the particles, but
also determines the important interaction factors. Factorial
DOE was utilized in this study to investigate the contribution of
each input parameter on the process outputs. An improved
insight into the relevance of the applicable parameters along
with their interactions on the output parameters such as
eﬃciency, size, and yield can enhance our understanding of the
particle fabrication process.
The DOE methodology oﬀers an eﬃcient approach in the
determination of signiﬁcant contributing factors while reducing
bias and the total number of trials. In electrospraying, there are
many controllable parameters that have an impact in particle
fabrication, which include surface tension, dielectric constant,
density, viscosity of the solution, and the vapor pressure of
solvent.23,24 These parameters are all dependent on the
composition of the jetting solution. Secondary factors such as
applied voltage, needle tip to collector distance, and environ-
mental factors like ambient temperature and humidity also
aﬀect the experimental outcome. However, in a typical
experiment, these secondary factors remain approximately
constant. We note that the applied voltage required to deform
the coaxial meniscus into the corresponding Taylor cone may
vary slightly between experiments.25 A set of 16 experimental
trials was conducted through the study of the experimental
space as described in the design matrix (Table 1). The order of
the experiments was randomized to reduce bias.26 Table 1 lists
the ﬁve experimental factors that were chosen at two levels for
this study. By deﬁnition, levels are deﬁned as the speciﬁc
quantities assumed for each of the factors. These ﬁve
experimental factors were bovine serum albumin (BSA)
concentration (A), core ﬂow rate (B), PLGA concentration
(C), shell solvent ratio (D), and shell ﬂow rate (E). It was
assumed based on prior experience that these factors have the
most eﬀect on the morphology and yield of core−shell
particles. The speciﬁc quantities selected for each parameter
were based on initial studies and the stability of the Taylor cone
during the EHD jetting process. Preliminary data (not shown)
suggested that the stability of the Taylor cone is predominantly
Figure 1. Schematic illustration of coaxial electrohydrodynamic (EHD) jetting. The viscoelastic polymer shell and the cell-loaded core solutions are
forced through a coaxial needle under applied electric potential resulting in cell encapsulated core−shell microparticles.
Table 1. Factors with the Corresponding Levels Used in the
Construction of the Experimental Space
model parameters’ factor levels studied
experimental
factors
number of
levels low high
BSA
concentration
(A)
2 10% w/v 20% w/v
core ﬂow rate
(B)
2 0.02 mL h−1 0.1 mL h−1
PLGA
concentration
(C)
2 10% w/v 15% w/v
shell solvent ratio
(D)
2 90:10 v/v CHCl3/DMF 97:3 v/v
CHCl3/DMF
shell ﬂow rate
(E)
2 0.1 mL h−1 0.5 mL h−1
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dependent on the polymer solutions used for jetting. These
conﬁning parameters include the volatility, concentration, and
the dielectric constant of the solutions used for the electro-
spraying process. The more concentrated the polymer solution
is, the more gradual the precipitation process becomes, which
results in fabrication of particles with higher sphericity.27 Here,
PLGA solutions with a mixture of chloroform and dimethyl-
formamide (DMF) with polymer concentrations of 10% (w/v)
and 15% (w/v) were chosen because higher PLGA
concentrations resulted in ﬁber formation. Chloroform has a
higher volatility than DMF and constitutes the majority of the
solvent. On the other hand, DMF has a higher dielectric
constant and tends to increase the stability of the Taylor cone
during particle fabrication. Consequently, chloroform/DMF
ratios of 97:3 and 90:10 (v/v) were chosen as the two levels for
this study. The addition of BSA to the core solution was
thought to improve the overall biocompatibility of polymer
microcapsules and to increase cell viability. BSA also increased
the viscosity of the core solution and thus stabilized the EHD
jet. The two levels for the BSA concentration were 10% (w/v)
and 20% (w/v). Flow rates of 0.1 and 0.5 mL h−1 were selected
for the shell solution, and 0.02 and 0.1 mL h−1 were chosen for
the core solution, by taking into account the diameter
diﬀerences in the jetting needles and to reduce the
polydispersity of the particles that are often observed with
higher ﬂow rates.28,29
Once the design space for each parameter was determined,
particles were prepared under conditions deﬁned by the overall
matrix of all available options. After completion of the 16
experimental runs, the data was analyzed to identify the eﬀects
of each contributing factor in the fabrication of core−shell
particles. The DOE analysis was carried out for three diﬀerent
experimental responses: (i) core encapsulation eﬃciency, (ii)
yield, and (iii) size.
2.1. Core Encapsulation Eﬃciency. Core encapsulation
eﬃciency is the fraction of particles that feature a core/shell
architecture, that is, the fraction of particles that are intact
microcapsules. Because both the core (red) and the shell (blue)
compartments were ﬂuorescent, the microcapsules could be
analyzed using ﬂow cytometry. Excitation intensity of DAPI
(blue ﬂuorescence) from a dye added to the polymer shell and
Texas red (red ﬂuorescence) from a dye added to the core
revealed the percentage of particles in each experiment that
were fully intact microcapsules. After the collection of data for
each of the 16 experimental runs, DOE analysis was performed.
Apart from studying the impact of the ﬁve main eﬀects, DOE
can also assist in the identiﬁcation of statistically signiﬁcant
two-factor interactions. Subsequently, the interaction eﬀects
that were least signiﬁcant (highest p-value) in core
encapsulation eﬃciency were systematically eliminated from
the model until each interaction had a p-value below 0.05 (95%
conﬁdence level) (Figure 2).
As shown in Figure 2, four two-factor interactions and two
main factors are signiﬁcantly inﬂuencing the core encapsulation
eﬃciency at a 95% conﬁdence level. The Pareto chart of eﬀects
(Figure 2C) reveals the signiﬁcance of each eﬀect against a
reference line. Any main or two-factor interaction eﬀect that
surpasses the reference line is considered statistically signiﬁcant
(p-value <0.05).
For core encapsulation eﬃciency, the two main factors are
the PLGA concentration and the shell solvent ratio. Relevant
two-factor interactions include AB (BSA concentration and
core ﬂow rate), BC (core ﬂow rate and PLGA concentration),
BE (core ﬂow rate and shell ﬂow rate) and DE (shell solvent
ratio and shell ﬂow rate). Interestingly, the most dominant two-
factor interaction is AB, both of which are independent of the
shell ﬂow. This dominance is apparent through the interaction
plot, wherein AB has the largest slope diﬀerence (Figure 2C).
In an interaction plot, the greater the diﬀerence in slopes
between the two lines, the greater the degree of interaction
between those factors. Hence, parallel lines in the interaction
plot indicate the absence of interactions. Knowledge of the
Figure 2. Determination of signiﬁcant contributing factors in encapsulation eﬃciency. (a) Interaction plot for core encapsulation eﬃciency. (b)
Contour plot of core encapsulation eﬃciency vs. core ﬂow rate and BSA concentration, where PLGA concentration, shell solvent ratio, and shell ﬂow
rate are all held constant at 12.5% w/v, 93.5:6.5 v/v CHCl3/DMF, and 0.3 mL h
−1, respectively. (c) Pareto chart of signiﬁcant contributing factors in
core encapsulation eﬃciency. Experimental factors are as follows: (A) BSA concentration, (B) core ﬂow rate, (C) PLGA concentration, (D) shell
solvent ratio, and (E) shell ﬂow rate.
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main and two-factor interactions that contribute to the
encapsulation eﬃciency along with their absolute value was
utilized to generate a model (Figure S1). This predictive model,
which is not shown here, was then used to generate a contour
plot. In Figure 2B, the relationship between core encapsulation
eﬃciency, core ﬂow rate, and BSA concentration is summarized
in the contour plot: Core ﬂow rate and BSA concentration have
to be selected concurrently to have a positive eﬀect on the
eﬃciency. The range of these parameters in the lower left
corner is roughly 0.02−0.035 mL h−1 for the core ﬂow rate and
10−12% (w/v) for the BSA concentration. In the upper right
hand corner, this range is between 0.09 and 0.1 mL h−1 for the
core ﬂow rate and between 19 and 20% (w/v) for the BSA
concentration.
2.2. Microcapsule Yield. Here, the microcapsule yield is
deﬁned as the number of particles prepared per mass of PLGA
used. The number of particles was measured using a
hemocytometer. Figure 3 displays the analyses that followed
the experimental approach described in the previous section.
Similar to core encapsulation eﬃciency, systematic elimi-
nation of insigniﬁcant parameters from the model yielded a
Pareto chart that identiﬁed the main factors and two-factor
interactions.
As shown in Figure 3C, the main contributing factor is core
ﬂow rate. Moreover, there are two signiﬁcant two-factor
Figure 3. Determination of signiﬁcant contributing factors in microcapsule yield. (a) Interaction plot for the yield of microparticles. (b) Contour plot
of yield vs shell ﬂow rate and shell solvent ratio, where BSA concentration, core ﬂow rate, and PLGA concentration are all held constant at 15% w/v,
0.06 mL h−1, and 12.5% w/v, respectively. (c) Pareto chart of signiﬁcant contributing factors in determination of yield. Experimental factors are as
follows: (A) BSA concentration, (B) core ﬂow rate, (C) PLGA concentration, (D) shell solvent ratio, and (E) shell ﬂow rate.
Figure 4. Determination of signiﬁcant contributing factors in microcapsule size. (a) Interaction plot for the size of microparticles. (b) Contour plot
of size vs core ﬂow rate and BSA concentration, where PLGA concentration, shell solvent ratio, and shell ﬂow rate are all held constant at 12.5% w/v,
93.5:6.5 CHCl3/DMF, and 0.3 mL h
−1, respectively. (c) Pareto chart of signiﬁcant contributing factors in the determination of size. Experimental
factors are as follows: (A) BSA concentration, (B) core ﬂow rate, (C) PLGA concentration, (D) shell solvent ratio, and (E) shell ﬂow rate.
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interactions: DE (shell solvent ratio and shell ﬂow rate) and AC
(BSA concentration and PLGA concentration). As described in
the case of core encapsulation eﬃciency, the slope diﬀerences
in the interaction plot are indicative of the signiﬁcance of each
interaction (Figure 3A). Because DE (shell solvent ratio, shell
ﬂow rate) has the largest slope diﬀerences and utmost
signiﬁcance, a contour plot displaying the relationship between
yield, shell ﬂow rate, and shell solvent ratio has been prepared
(Figure 3B). Similar to core encapsulation eﬃciency analysis,
the contour plot was generated using a predictive model, which
is not shown here (Figure S2). According to Figure 3B, to
maximize yield, a shell ﬂow rate in the range of 0.4−0.5 mL h−1
is recommended; however, the shell/solvent ratio should be in
the range of 96:4−97:3 (v/v) chloroform and DMF. Note that
even though AD (BSA concentration and shell solvent ratio)
did not have a signiﬁcant eﬀect on the yield of core−shell
particles, it was not eliminated in the analysis process because
the predictive model used in development of the contour plot
had a signiﬁcantly higher coeﬃcient of determination (R2),
when including this two-factor interaction in the analysis.
2.3. Microcapsule Size. In addition to core encapsulation
eﬃciency and yield, particle size is a critical property for any
biomedical application involving cell-laden microcapsules.30 A
corresponding DOE analysis was thus also carried out to
determine the signiﬁcant main and interaction factors aﬀecting
the size of core−shell particles. The data for this analysis are
presented in Figure 4.
According to the size distribution Pareto chart (Figure 4C),
there are three main factors and two two-factor interactions
that signiﬁcantly inﬂuence the size of microcapsules. The three
main factors are the shell solvent ratio, the core ﬂow rate, and
the shell ﬂow rate. The two-factor interactions are AB (BSA
concentration, core ﬂow rate) and BC (core ﬂow rate, PLGA
concentration). Because the interaction between BSA concen-
tration and core ﬂow rate is the most dominant, a contour plot
displaying the relationship between size, core ﬂow rate, and
BSA concentration was generated (Figure 4B). Similar to core
encapsulation eﬃciency and yield analysis, the contour plot was
generated using a predictive model, which is not shown here
(Figure S3). According to the contour plot, the size of the
microcapsules is independent of the core ﬂow rate for BSA
concentrations between 10 and 12.5% (w/v). These BSA
concentrations also yielded the most monodisperse particles.
However, as the concentration of BSA increases, the variance of
the particle size increases concurrently. Because the goal of the
experiment is to encapsulate primary mammalian cells with an
estimated diameter of 8−10 μm; 8−10 μm was deﬁned as the
target value for the microcapsules. On the basis of this analysis,
we came to know that there are two distinct regions that result
in the highest encapsulation eﬃciency. Those regions were with
core ﬂow rates between 0.02 and 0.035 mL h−1 in conjunction
with 10−12% (w/v) BSA concentrations, or core ﬂow rates
between 0.09 and 0.1 mL h−1, if the BSA concentrations were
between 19 and 20% (w/v). Because both encapsulation
eﬃciency and size are dependent on the combination of core
ﬂow rate and BSA concentration, an overlapping region with
core ﬂow rate 0.02−0.035 mL h−1 and 10−12% w/v BSA
concentration can be identiﬁed, wherein the encapsulation
eﬃciency is maximum and the size target can be met.
Figure 5. Fabrication of core−shell microparticles: (a) SEM image of uniform microparticles, (b-1) superimposed DAPI and Texas red channels of
CLSM image of microparticles; (b-2) CLSM image of the DAPI channel, showing the PLGA shell layer containing blue dye; (b-3) CLSM image of
the Texas red channel, showing the BSA core layer containing red silica microspheres; (b-4) lower-resolution superimposed CLSM image of
microparticles; (b-5) zoomed-out CLSM image of the DAPI channel, showing the PLGA shell layer containing blue dye; (b-6) zoomed-out CLSM
image of the Texas red channel, showing the BSA core layer containing red silica microspheres; (c-1) SEM image of cross-sectioned BSA layer
containing a silica microsphere; (c-2) SEM image of cross-sectioned PLGA layer; (c-3) SEM image of cross-sectioned PLGA layer; and (c-4) SEM
image of cross-sectioned BSA layer.
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2.4. Preparation of Cell-Laden Microcapsules. The
relationships demonstrated in Figures 2−4 provided a detailed
understanding of the main operating parameters for the
fabrication of uniform, cell-laden microcapsules in high yields.
On the basis of this analysis, a BSA concentration of 10% w/v,
core ﬂow rate of 0.02 mL h−1, PLGA concentration of 10% w/
v, shell solvent ratio of 97:3 v/v chloroform/DMF, and shell
ﬂow rate of 0.5 mL h−1 were selected as the operating
parameters for cell encapsulation. Core−shell particles were
then fabricated using these parameters to validate the statistical
model. Because this experiment was carried out to evaluate the
practicality and the feasibility of core−shell particle fabrication,
cells were not added to the core solution. Instead, red silica
microspheres were added to the core solution to be
encapsulated instead of cells. The fabricated core−shell
particles were then collected and suspended in an optimum
cutting temperature gel. The gel was frozen at −70 °C and
sectioned via a cryosectioning machine. These sectioned
particles were mounted on a glass slide and imaged via
scanning electron microscopy (SEM) and confocal laser
scanning microscopy (CLSM). These images were used to
qualitatively evaluate the outcome of this experiment. Figure 5
presents the images obtained from EHD jetting of core−shell
particles and their internal architecture.
As evident from the images displayed in Figure 5, core−shell
particles were successfully fabricated using the parameters
derived from the aforementioned analysis. From the SEM
image, it can be deduced that the microparticles have been
fabricated in high yields (Figure 5A). The CLSM images along
with cross-sectional SEM images reveal the success of core−
shell particle formation and their morphology. In CLSM
images, red silica microspheres and blue dye were used as the
markers for the core and shell, respectively (Figure 5B). Figure
5C presents the SEM images of the sectioned particles after
cryosectioning. It is evident that the silica microspheres have
been successfully encapsulated within the BSA layer to form the
core, and the core has been entrapped within the PLGA shell.
2.5. Cell Viability. After ensuring the synthesis of core−
shell particles, microencapsulation of live NIH3T3 ﬁbroblast
cells was investigated. The core and shell solutions were
prepared as explained in detail in the Section 4 and fabricated
using the parameters obtained from the DOE analysis. The
polymeric shell solution contained a blue dye, and NIH3T3
cells were stained with the live/dead assay. The particles were
jetted into a solution of Dulbecco’s modiﬁed Eagle’s medium
(DMEM) to ensure that the cells would survive. Figure 6
presents the data obtained through this analysis.
Figure 6A presents the confocal images of the cell-loaded
core−shell particles. An examination of the ﬂuorescent signals
Figure 6. GFP-NIH3T3 cell microencapsulation. (a-1) CLSM image of GFP-NIH3T3 cell-core/PLGA-shell microparticles (superimposed green
and blue channels); (a-2) CLSM image of PLGA shells (blue channel); (a-3) CLSM image of GFP-NIH3T3 cells in BSA core (green channel); (b-
1) ﬂow cytometry analysis of encapsulation eﬃciency of core−shell microparticles not encapsulating GFP-NIH3T3 cells with PLGA (blue dye) shell
and BSA core layers (control); and (b-2) ﬂow cytometry analysis of encapsulation eﬃciency of core−shell microparticles encapsulating GFP-
NIH3T3 cells with PLGA (blue dye) shell and BSA core layers.
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of blue and green dyes using ﬂow cytometry reveals that 76.2%
of the cells were alive and had been successfully encapsulated in
the core. Figure 6B shows the dot plot of the particles wherein
the control microparticles, negative for the green signal, fell in
the lower left quadrant. Microparticles loaded with stained cells
were conﬁned in the upper two quadrants characterized by
their ﬂuorescence signal. This evaluation is also proof of the
viability of cells after encapsulation and shows that the cells
were capable of withstanding the applied voltage. Figure 7
shows the confocal images obtained before and after micro-
encapsulation of stained cells. Figure 7A shows the stained
NIH3T3 cells before entrapment in microcapsules. The color
green represents live cells and red represents the dead ones.
Figure 7B demonstrates the stained NIH3T3 cells after
microencapsulation in PLGA core−shell particles.
3. CONCLUSIONS
In this study, a modiﬁed electrospraying approach was
successfully utilized to fabricate core−shell particles encapsulat-
ing live cells. The eﬀect of each jetting parameter on
encapsulation eﬃciency, yield, and size was studied systemati-
cally using DOE methodology. Contour plots of the relation-
ship between each response and the most dominant aﬀecting
experimental factors were displayed. It was demonstrated that
the interactions between BSA concentration and core ﬂow rate
is the most dominant factor aﬀecting core encapsulation
eﬃciency and size of the core−shell particles. Furthermore, it
was shown that the interaction between shell solvent ratio and
shell ﬂow rate is the most dominant factor aﬀecting the yield of
core−shell particles. We further identiﬁed the optimum
operating parameters for core−shell particles synthesis: 10%
w/v BSA concentration, 0.02 mL h−1 core ﬂow rate, 10% w/v
PLGA concentration, 97:3 chloroform/DMF v/v solvent ratio,
and 0.5 mL h−1 shell ﬂow rate. For proof of concept, NIH3T3
cells were successfully encapsulated in core−shell micro-
particles using the parameters obtained from the DOE analysis.
It was shown that the cells were alive and able to withstand the
applied electric potential during EHD jetting. In the future, cell
delivery via microencapsulation of cells in biodegradable, semi-
impermeable particles may have applications in tissue engineer-
ing, regenerative medicine, as well as vehicles for the
production and secretion of hormones and growth factors,
such as insulin.
4. EXPERIMENTAL SECTION
4.1. Materials. Poly(lactic-co-glycolic acid) (PLGA, 50:50
lactic acid to glycolic acid ratio, and molecular weight (Mw) of
44 kDa) was purchased from Corbin (Lenexa, KS). BSA,
chloroform, DMF, Tween 20, and poly[(m-phenyleneviny-
lene)-alt-(2,5-dihexyloxy-p-phenylenevinylene)] (MEHPV)
were obtained from Sigma Aldrich (St. Louis, MO) and used
as received. m-PEG-rhodamine (5 kDa) was used as received
from Creative PEGWorks (Chapel Hill, NC), and the OCT
compound was purchased from Fisher HealthCare (Houston,
TX). The mouse embryonic ﬁbroblast cell line, NIH3T3 cells
were obtained from ATCC (Manassas, VA). Calcein AM and
ethidium homodimer were both purchased from Life
Technologies (Carlsbad, CA). DMEM and tryspin were
obtained from Gibco (Grand Island, NY).
4.2. Preparation of Jetting Solutions. PLGA was
dissolved in a solvent consisting of chloroform and DMF to
be used as the shell. The formulation of this polymeric solution
was varied in accordance with the DOE matrix outlined in
Section 2.4 (Table 1). BSA was dissolved in the water/
rhodamine mixture, and the resulting solvent was used as the
core solution, with its formulation varied in accordance with the
DOE matrix (Table 1) to optimize the particle formulation.
After the particle formulation was optimized, the core solution
was replaced with NIH3T3 mouse ﬁbroblasts suspended in a
10% Matrigel (Corning, NY) solution at a concentration of 2
million cells/mL. These NIH3T3 mouse ﬁbroblasts were
cultured under standard conditions at 37 °C with 5% CO2.
The Matrigel was diluted in DMEM (4.5 g/mL) containing 4
mM L-glutamine, 10% fetal bovine serum, 1% penicillin−
streptomycin, and 1% MEM nonessential amino acids (Gibco,
Grand Island, NY). The samples were washed with PBS and
resuspended in a solution of DMEM and 10% Matrigel.
4.3. EHD Cojetting. A coaxial needle system, which
consisted of a 25-gauge needle centered within an 18-gauge
needle, was used to synthesize the core−shell microparticles.
The PLGA solution was loaded into the outer needle to make
the shell of the particles, and the BSA solution was loaded into
the central needle to make the particle core. The ﬂow rates for
both the PLGA and BSA solutions were varied according to the
DOE matrix (Table 1). After the respective solutions were
loaded into the needles, a voltage was applied until a stable
Taylor cone was formed, as illustrated in Figure 1. A voltage of
10−12 kV was used for all experiments. For the DOE analysis,
Figure 7. In vitro cell viability of NIH3T3 cells encapsulated in core−shell microparticles. (a) CLSM image of NIH3T3 cells stained with Live/Dead
assay kit (green: live/red: dead) demonstrating NIH3T3 cells before encapsulation in core−shell particles. (b) CLSM image of NIH3T3 cells stained
with Live/Dead assay kit (green: live/red: dead) encapsulated in core−shell microparticles.
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microparticles were deposited onto a metal sheet and placed in
vacuum to dry. For cellular encapsulation, the particles were
jetted into DMEM. The solution was then passed through a 40
μm ﬁlter followed by a 20 μm ﬁlter and then centrifuged at
3000 rpm. The puriﬁed particles were then resuspended in
DMEM.
4.4. Formulating the Experimental Design for Micro-
encapsulation of Cells. A half-fraction factorial design with
ﬁve experimental factors and two levels was used to explore the
experimental space and obtain optimal operating parameters.
Table 1 illustrated the model parameters used in the
construction of the experimental space. The experimental
factors are the inputs of the design. Core encapsulation
eﬃciency, yield, and size identify the outputs or the response of
the experimental design.
This combination of parameters gave rise to the 16 unique
experimental combinations used to map the experimental
space. The experimental run order was randomized to minimize
bias and ensure that the data points were independent. This
elimination was done to avoid convolution of the model.
4.5. Characterization of Jetted Microparticles. Micro-
particles were imaged with a CLSM using a Nikon A-1 spectral
microscope and SEM (Amray 1910 FE-SEM) at the University
of Michigan’s Microscopy and Imaging Laboratory facilities.
For the purpose of the DOE analysis, the samples for confocal
and SEM imaging were obtained by placing a microscope cover
glass and a silicon chip on the collectors’ metal sheet during
EHD cojetting. In the case of cellular encapsulation, these
samples were obtained from the solution after the centrifuga-
tion step outlined in Section 4.3. The sample was then
mounted in 7 μL of prolong gold (Invitrogen, Eugene, OR)
before the confocal analysis. In DOE analysis, confocal images
were used to ensure the fabrication of the core−shell particles
for each combination of parameters according to the DOE
matrix outlined in Section 2.4 (Table 1). The SEM images were
used to conﬁrm particle formation and to measure the diameter
of microparticles. This measurement was done using Image-J
software.31−33 For cellular encapsulation, confocal images were
used to ensure successful cell encapsulation as determined by
staining with a live/dead assay kit. To demonstrate the internal
core−shell geometry of these particles, SEM images of
microparticles sectioned into 30 μm sections were used.
Furthermore, for the purposes of the DOE analysis, the yield
was determined by collecting the microparticles and dispersing
them in a solution of 0.1% PBS and Tween 20. These particles
were analyzed using a hemocytometer and the actual
concentration of particles per mass of PLGA jetted was
calculated.
Core−shell microparticles suspended in PBS with 0.1%
Tween 20 were analyzed by ﬂow cytometry at the University of
Michigan ﬂow laboratory. The data obtained from ﬂow
cytometry was evaluated to determine the core encapsulation
eﬃciency using the percentage of particles that had both red
and blue dyes associated with them. In cellular encapsulation,
the control group of particles (no cell encapsulated) and
particles encapsulating NIH3T3-GFP cells were prepared as
stated and analyzed by ﬂow cytometry to determine the cell
encapsulation eﬃciency. For data analysis, the MoFlo Astrios
software was used.
4.6. Cell Viability. The cell viability was evaluated by
confocal microscopy using calcein AM and ethidium homo-
dimer. First, the cells were passaged at 80% conﬂuence using
0.25% tryspin, which was neutralized with a three-fold excess of
the complete medium. The cells were then centrifuged at 300g
for 5 min at 4 °C. Next, the cell pellet was washed in
Dulbecco’s phosphate-buﬀered saline (DPBS) and then
pelleted using centrifugation. The cells were then treated with
a solution of 1 μM calcien AM and 2 μM ethidium homodimer
in DPBS for 20 min at room temperature. The cells were rinsed
three times before suspending them in the core solution, which
contained 2 μM ethidium homodimer to track changes in cell
viability within the particles after encapsulation.
4.7. Statistical Analysis. Analysis of variance (ANOVA)
was used to identify both the main and the interaction eﬀects
signiﬁcant in each response. This analysis was conducted at
95% conﬁdence level (5% signiﬁcance). Insigniﬁcant main and
interaction parameters were systematically eliminated from the
model and a contour plot of each reﬁned model was
constructed. ANOVA calculations were all performed using
Minitab statistical package (State College, PA).
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